Diabetes, Vol 33, Issue 11 1112-1119, Copyright © 1984 by American Diabetes Association

ARTICLES

Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes

KS Polonsky, KC Herold, JL Gilden, RM Bergenstal, VS Fang, AR Moossa and JB Jaspan

Glucose and counterregulatory hormone responses to a high-dose (1.7 mU/kg/min) insulin infusion were studied in 6 patients who had undergone total pancreatectomy, and the results were compared with those of normal controls and patients with other clinical forms of diabetes. The maximum increase in the plasma glucagon concentration during hypoglycemia in the pancreatectomized patients (5 +/- 5.6 pg/ml) was less than in normals (121 +/- 22 pg/ml). Type I diabetic subjects (28 +/- 14 pg/ml), and insulin-treated diabetic subjects of recent onset (36 +/- 12 pg/ml) also had reduced responses, while responses were normal in type II diabetic subjects (102 +/- 26 pg/ml). The epinephrine response to the hypoglycemic stimulus was reduced after pancreatectomy (278 +/- 81 pg/ml) and in type I diabetic subjects (628 +/- 244 pg/ml), but was not different from control (858 +/- 126 pg/ml) in type II and recent-onset diabetic patients. There was considerable overlap in counterregulatory hormone responses in individual patients with and without autonomic neuropathy and with normal or undetectable fasting C-peptide concentrations. While the control subjects all experienced symptoms of hypoglycemia within a narrow range of plasma glucose concentrations (35-46 mg/dl), five of the diabetic subjects experienced symptoms of hypoglycemia at plasma glucose levels of greater than or equal to 55 mg/dl, and five had no subjective awareness of hypoglycemia despite plasma glucose levels less than 30 mg/dl.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity Diabetes, June 1, 2003; 52(6): 1386 - 1392. [Abstract] [Full Text] [PDF]

				M. R. Burge, T. A. Sobhy, C. R. Qualls, and D. S. Schade Effect of Short-Term Glucose Control on Glycemic Thresholds for Epinephrine and Hypoglycemic Symptoms J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5471 - 5478. [Abstract] [Full Text] [PDF]

				L. Landstedt-Hallin, U. Adamson, and P.-E. Lins Oral Glibenclamide Suppresses Glucagon Secretion during Insulin-Induced Hypoglycemia in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3140 - 3145. [Abstract] [Full Text]

				B. Glaser, P. Kesavan, M. Heyman, E. Davis, A. Cuesta, A. Buchs, C. A. Stanley, P. S. Thornton, M. A. Permutt, F. M. Matschinsky, et al. Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation N. Engl. J. Med., January 22, 1998; 338(4): 226 - 230. [Full Text] [PDF]

				T. F. Veneman and D. W. Erkelens Hypoglycemia Unawareness in Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1682 - 1684. [Full Text] [PDF]